TipRanks
SAB Biotherapeutics (SABS)
NASDAQ:SABS
US Market
SABS
SAB Biotherapeutics
RESEARCH TOOLSreports
Want to see SABS full AI Analyst Report?

SAB Biotherapeutics (SABS) Balance Sheet

330 Followers

SAB Biotherapeutics Balance Sheet

SAB Biotherapeutics's total assets for Q2 2026 were $238.21M, a decrease of -4.13% from the previous quarter. SABS total liabilities were $23.43M for the fiscal quarter, a 10.38% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 25Mar 25Dec 23Mar 23Dec 21
Total Assets
$ 172.81M$ 44.20M$ 83.94M$ 50.90M$ 81.14M
Total Liabilities
$ 21.32M$ 18.23M$ 26.64M$ 19.85M$ 42.59M
Total Equity Gross Minority
$ 151.49M$ 25.97M$ 57.30M$ 31.06M$ 38.55M
Other Metrics
Currency in USD

SAB Biotherapeutics Debt to Assets